Data / Form D filings / Causeway Therapeutics Ltd
Causeway Therapeutics Ltd: Form D filing
Causeway Therapeutics Ltd, a biotechnology company in Glasgow, United Kingdom, filed a Form D with the SEC in 2023. The latest, on February 28, 2023, reports $14.3 million sold of a $14.3 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- C/O IMAGING CENTRE OF EXCELLENCE, QUEEN ELIZABETH UNIVERSITY HOSPITAL, Glasgow, United Kingdom, G51 4
- Phone
- 441414516822
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- United Kingdom
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1966914
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 28, 2023 | New notice | $14,263,627 | $14,263,627 | 10 | Feb 3, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Jones | Director | |
| Neil Gibson | Director | |
| Gregor Caldow | Director | |
| Neal Millar | Executive Officer | |
| David Armour | Executive Officer | |
| Declan Doogan | Director | |
| Alexander Picket | Director | |
| Derek Gilchrist | Executive Officer, Director |
Every Form D from the week of Feb 27, 2023 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Causeway Therapeutics Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.